Houston Methodist Division of Dermatology

The Houston Methodist Division of Dermatology provides expert diagnosis and treatment for conditions affecting the skin. Our commitment to addressing the most complex medical cases, coupled with our contribution to the development of new skin cancer therapies and modalities, has made us a trusted leader in the medical and research landscape. 


Our expert dermatologists deliver specialty outpatient and inpatient clinical services to people with skin reactions, skin infections, psoriasis, eczema, basal and squamous skin cancers, and malignant melanomas.  


We continually meet the highest surgical standards to provide the best care possible. Ranked No. 19 in the nation for cancer by U.S. News & World Report, we are a top dermatology destination and a robust referral center both in the Greater Houston area and nationwide.  


Through our fellowship training and academic collaborations, our trainees gain hands-on experience in these state-of-the-art modalities, preparing them to excel in treating both common and rare conditions. 


Our facilities are fully equipped to offer the latest diagnostic and treatment options, including minimally invasive procedures, immunotherapy and targeted therapies. Our residents and fellows train in these advanced technologies, preparing them to treat both common and complex conditions. 

Our Team

Our skin cancer specialists have extensive expertise in the diagnosis and treatment of all types of skin cancer, including basal cell and squamous cell carcinomas and melanoma. We also work with patients with dermatological issues who are simultaneously in the hospital for other conditions.


Besides complex skin cancer cases, our division members are experts in cosmetic and laser procedures, general dermatology, and specialty conditions such as psoriasis and alopecia. We have experience of treating more than 100,000 patients with skin cancer.  


Kindness, respect and collaboration are the tenets of our culture. Our faculty, researchers and residents experience a level of team-based support and knowledge sharing that helps Houston Methodist — and the medical community at large — further the world’s understanding and efficacious treatment of skin conditions.  

 

 

Our Faculty ➝   Our Physicians ➝ 

 

Ranked #19 in the Nation for Cancer Care by U.S. News & World Report


Houston Methodist Hospital is ranked a top hospital in the nation by U.S. News & World Report for cancer. U.S. News & World Report has also named Houston Methodist Hospital one of the nation's best as a nationally ranked Honor Roll hospital.


Learn More  ➝

Our Research

The Division of Dermatology is dedicated to clinical dermatological and skin cancer research, advancing the understanding and treatment of all skin conditions. To this end, we work within the American College of Mohs Surgery, the leading organization in managing skin cancer treatments in the country. 


Our experts are recognized speakers and authors of more than 360 peer-reviewed publications. We collaborate with Rice University, whose students perform research in our facilities.  


Division Chair Leonard Goldberg, MD, is the Fellowship Director for the American College of Mohs Surgery. A member of the Texas Dermatology Society and a past president of the Houston Dermatological Society, he is a recipient of the 2024 American Society for Dermatologic Surgery (ASDS) prestigious Presidential Award and also the Fredrick E Mohs M.D. Award for Career Achievement.

How To Optimize Epidermal Approximation During Wound Suturing Using a Smartphone Camera
Utilizing smartphone camera technology as a quality-control checkpoint for objective evaluation allows the dermatologic surgeon to scrutinize the wound edges and refine their surgical technique to improve scar outcomes. 
Nonablative Fractional Diode Laser Resurfacing (1440 nm and 1927 nm) for Photoaged Skin
Nonablative lasers treat photoaged skin and stimulate new collagen formation while sparing epidermal damage. 
Epidemiology, Survival and Risk of Subsequent Primary Malignancies in Patients
Digital papillary adenocarcinoma (DPAc) is a rare and aggressive cutaneous malignancy of sweat gland derivation. We conducted a retrospective study of 213 patients with DPAc using the 17 registries of the Surveillance, Epidemiology, and End Results (SEER) Program.
Assessment of Pain, Healing Time, and Postoperative Complications in the Healing of Auricular Defects
Reconstruction of auricular defects after Mohs surgery is challenging given the prominence of the ear and its complex 3-dimensional architecture.

Education & Training

We are dedicated to cultivating the next generation of skin cancer specialists, who will contribute to the field long after they complete their training. The passion we bring to our clinical practice extends to the education and training we provide. 


We offer, in partnership with DermSurgery Associates, a Dermatologic Oncology Fellowship. In this one-year fellowship, two fellows per year train with six or seven surgeons, gaining extensive training in Mohs micrographic surgery and reconstruction. Our faculty performs more than 5,000 Mohs procedures a year, with the fellow typically performing more than 1,000 cases as the primary surgeon. 


Our dermatologists also practice a variety of cosmetic procedures, including lasers, neuromodulators and fillers. The fellows will have a chance to interact with these physicians who specialize in cosmetic dermatology at various times throughout the year based on their interests.  


Our educational reach extends far beyond our fellowship program, as we regularly host Texas A&M, MD Anderson Cancer Center and Rice University students. 

EnMed: From Conception to Commencement
The revolutionary EnMed program partners Houston Methodist with Texas A&M University to transform health care through interdisciplinary translational research, medical technology development, and the training and development of “Physicianeers.” 
For Patients

For Patients

Houston Methodist dermatologists deliver specialty care, performing innovative surgical and therapeutic treatments on patients with skin cancer or a variety of skin diseases and issues.